Clinicopathological Characteristics and Prognosis of 91 Patients with Seromucinous and Mucinous Borderline Ovarian Tumors: a Comparative Study

Ovarian seromucinous tumors: clinicopathological features of 10 cases with a detailed review of the literature, Journal of Ovarian Research

Diagnosis, treatment, and follow-up of borderline ovarian tumors. - Abstract - Europe PMC

A combination of immunohistochemical markers, MUC1, MUC5AC, PAX8 and growth pattern for characterization of mucinous neoplasm of the ovary

Incidence rate of borderline ovarian tumors 1997‐2018 stratified by

PDF) Mucinous borderline ovarian tumors: Analysis of 75 patients from a single center

Comprehensive genomic profiling reveals ubiquitous KRAS mutations and frequent PIK3CA mutations in ovarian seromucinous borderline tumor - ScienceDirect

Current Update on Borderline Ovarian Neoplasms

Representation of the final study population following quantitative

Ovarian mucinous and seromucinous neoplasms: problematic aspects and modern diagnostic approach - Talia - 2022 - Histopathology - Wiley Online Library